Literature DB >> 30516090

Using sedative substances until death: A mortality follow-back study on the role of healthcare settings.

Sarah Ziegler1, Margareta Schmid1, Matthias Bopp1, Georg Bosshard2, Milo Alan Puhan1.   

Abstract

Keywords:  Alleviation of pain; deep sedation; end-of-life practices; healthcare setting

Mesh:

Substances:

Year:  2018        PMID: 30516090     DOI: 10.1177/0269216318815799

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


× No keyword cloud information.
  5 in total

1.  Sedatives and Sedation at the End of Life in the Hospital.

Authors:  Eva Schildmann; Sophie Meesters; Claudia Bausewein
Journal:  Dtsch Arztebl Int       Date:  2022-05-27       Impact factor: 8.251

2.  Continuing, Withdrawing, and Withholding Medical Treatment at the End of Life and Associated Characteristics: a Mortality Follow-back Study.

Authors:  Yolanda W H Penders; Matthias Bopp; Ueli Zellweger; Georg Bosshard
Journal:  J Gen Intern Med       Date:  2019-10-25       Impact factor: 5.128

3.  Automated Stereotactic Gamma Ray Radiosurgery to the Pituitary Gland in Terminally Ill Cancer Patients with Opioid Refractory Pain.

Authors:  Eduardo E Lovo; Fidel J Campos; Victor E Caceros; Mario Minervini; Claudia B Cruz; Juan C Arias; William A Reyes
Journal:  Cureus       Date:  2019-06-03

4.  Possible age-related differences in healthcare professionals' perspectives on younger and older patients' autonomy and decision-making in the context of sedation in specialised palliative care: exploratory secondary qualitative content and linguistic conversation analysis of interviews with healthcare professionals.

Authors:  Sandra Kurkowski; Maria Heckel; Larissa Pfaller; Joachim Peters; Jeremias Bazata; Eva Schildmann; Christoph Ostgathe
Journal:  BMC Palliat Care       Date:  2022-05-13       Impact factor: 3.113

5.  How should health care providers inform about palliative sedation? A qualitative study with palliative care professionals.

Authors:  Allan Cocker; Pascal Singy; Ralf J Jox
Journal:  Eur J Cancer Care (Engl)       Date:  2022-04-29       Impact factor: 2.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.